Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oralair Phase IIb/III Study in Adults with Grass Pollen Rhinoconjunctivitis
NCT00367640Phase 3Completed
- Sponsor
- Stallergenes Greer
- Start
- Nov 2004
- Primary completion
- Sep 2005
- Modality
- Allergy Immunotherapy
01
Overview
A Phase 3 trial of Oralair in allergic rhinoconjunctivitis (ARC), sponsored by Stallergenes Greer. Started Nov 2004; status: completed.
02
Drugs
Oralair
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT00367640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367640.